Search - tctmd.com

Displaying 541 - 560 of 568

Sort: Relevancy | Date

Presentation TVT 2012

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Presenter: Gregg Stone

June 05, 2012

Presentation TVT 2012

Left Atrial Appendage Anatomy: An Anatomical Imaging Review and Implications for Stroke Prevention

Presenter: Rebecca Hahn

June 05, 2012

Presentation

Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: S. Lee

June 05, 2012

Presentation

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

Presenter: T. Tada

June 01, 2012

Presentation TCT Russia 2012

DES Thrombosis: Emerging Concepts into Mechanisms and Prevention

Presenter: Gary S. Mintz

May 28, 2012

Presentation

New Oral Anticoagulants for Stroke Prevention

Presenter: Nicole R. Gonzales

May 02, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCTAP 2012

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

Presenter: Corrado Tamburino

April 25, 2012

Presentation GI2 2012

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

Presenter: Fausto Feres

April 13, 2012

Presentation GI2 2012

New Agents and Prevention of Contrast Induced Nephropathy

Presenter: George Dangas

April 12, 2012

Presentation

Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting

Presenter: Marco Valgimigli

April 02, 2012

Presentation ACC 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presenter: Myeong-Ki Hong

March 25, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

Presentation PCI Outcomes 2012

Prevention and Treatment of Stent Thrombosis

Presenter: Ajay J. Kirtane

March 23, 2012

Presentation

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Presenter: Hans-Christoph Diener

March 08, 2012

Presentation

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Presenter: S. Friedland

March 06, 2012

Presentation

Meta-Análisis of Ensayos Controlados Aleatorizaos sobre el Efecto del Cilostazol en la Re-estenosis y Resultados tras PCI

Presenter: S. Friedland

March 06, 2012

Presentation

Sodium Chloride vs. Sodium Bicarbonate for the Prevention of Contrast Induced Nephropathy (CIN)

Presenter: T. Klima

January 23, 2012

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

Presentation

Prevention of Contrast Nephropathy by Furosemide with Matched Hydration

Presenter: Giancarlo Marenzi

January 17, 2012

Advertisement

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Left Atrial Appendage Anatomy: An Anatomical Imaging Review and Implications for Stroke Prevention

Cost-effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Duration of DAPT and Long-term Clinical Outcome After Coronary DES Implantation

DES Thrombosis: Emerging Concepts into Mechanisms and Prevention

New Oral Anticoagulants for Stroke Prevention

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

New Agents and Prevention of Contrast Induced Nephropathy

Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Prevention and Treatment of Stent Thrombosis

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Meta-Análisis of Ensayos Controlados Aleatorizaos sobre el Efecto del Cilostazol en la Re-estenosis y Resultados tras PCI

Sodium Chloride vs. Sodium Bicarbonate for the Prevention of Contrast Induced Nephropathy (CIN)

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Prevention of Contrast Nephropathy by Furosemide with Matched Hydration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content